These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Testing of chemotherapeutic agents in murine renal cell adenocarcinoma. Murphy GP; Williams PD Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):265-77. PubMed ID: 4438832 [No Abstract] [Full Text] [Related]
5. Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer. Hahn RG; Temkin NR; Savlov ED; Perlia C; Wampler GL; Horton J; Marsh J; Carbone PP Cancer Treat Rep; 1978 Jul; 62(7):1093-5. PubMed ID: 356971 [TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037). Einhorn LH; Livingston RB; Gottlieb JA Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951 [No Abstract] [Full Text] [Related]
7. Combination chemotherapy with CCNU (NSC-79037) and 5-(3, 3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196). Chang H; Freireich EJ; Khaliq A; Einhorn L; Gottlieb JA Cancer Chemother Rep; 1975; 59(4):769-71. PubMed ID: 1100230 [No Abstract] [Full Text] [Related]
8. Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU. Omura G; DiSaia P; Blessing J; Boronow R; Hreshchyshyn M; Park R Cancer Treat Rep; 1977 Nov; 61(8):1533-5. PubMed ID: 922756 [TBL] [Abstract][Full Text] [Related]
9. Lomustine treatment of metastatic renal cell carcinoma. Mittelman A; Albert DJ; Murphy GP JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302 [No Abstract] [Full Text] [Related]
10. Evaluation of chemotherapeutic agents in a new murine renal carcinoma model. Hrushesky WJ; Murphy GP J Natl Cancer Inst; 1974 Apr; 52(4):1117-22. PubMed ID: 4826582 [No Abstract] [Full Text] [Related]
11. Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer. Richards F; Pajak TF; Cooper MR; Spurr CL Cancer Chemother Rep; 1973; 57(4):419-22. PubMed ID: 4357670 [No Abstract] [Full Text] [Related]
12. Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer. Hahn RG; Begg CB; Davis T Cancer Treat Rep; 1981; 65(7-8):711-13. PubMed ID: 7018680 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of advanced transitional cell carcinoma of the renal pelvis: report of 3 cases treated with vinblastine and chloroethyl-cyclohexyl-nitrosourea. von Eyben F; Mattsson W; Glifberg I; Lindholm CE J Urol; 1979 Mar; 121(3):367-8. PubMed ID: 430637 [TBL] [Abstract][Full Text] [Related]
15. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer. Perloff M; Muggia FM; Ackerman C Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718 [No Abstract] [Full Text] [Related]
17. Letter: CCNU in teatment of recurrent medulloblastoma. Ward HW Br Med J; 1974 Mar; 1(5908):642. PubMed ID: 4206861 [No Abstract] [Full Text] [Related]
18. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model. Williams PD; Kantor P; Murphy GP Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884 [TBL] [Abstract][Full Text] [Related]
19. Combination of vinblastine and bleomycin in metastatic renal cell carcinoma. Knost JA; Oldham RK; Hande KR; Rhamy RK; Greco FA Cancer Treat Rep; 1981; 65(3-4):349-50. PubMed ID: 6165469 [No Abstract] [Full Text] [Related]
20. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]